TY - JOUR
T1 - Tutorial
T2 - using nanoneedles for intracellular delivery
AU - Chiappini, Ciro
AU - Chen, Yaping
AU - Aslanoglou, Stella
AU - Mariano, Anna
AU - Mollo, Valentina
AU - Mu, Huanwen
AU - De Rosa, Enrica
AU - He, Gen
AU - Tasciotti, Ennio
AU - Xie, Xi
AU - Santoro, Francesca
AU - Zhao, Wenting
AU - Voelcker, Nicolas H.
AU - Elnathan, Roey
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2021/10
Y1 - 2021/10
N2 - Intracellular delivery of advanced therapeutics, including biologicals and supramolecular agents, is complex because of the natural biological barriers that have evolved to protect the cell. Efficient delivery of therapeutic nucleic acids, proteins, peptides and nanoparticles is crucial for clinical adoption of emerging technologies that can benefit disease treatment through gene and cell therapy. Nanoneedles are arrays of vertical high-aspect-ratio nanostructures that can precisely manipulate complex processes at the cell interface, enabling effective intracellular delivery. This emerging technology has already enabled the development of efficient and non-destructive routes for direct access to intracellular environments and delivery of cell-impermeant payloads. However, successful implementation of this technology requires knowledge of several scientific fields, making it complex to access and adopt by researchers who are not directly involved in developing nanoneedle platforms. This presents an obstacle to the widespread adoption of nanoneedle technologies for drug delivery. This tutorial aims to equip researchers with the knowledge required to develop a nanoinjection workflow. It discusses the selection of nanoneedle devices, approaches for cargo loading and strategies for interfacing to biological systems and summarises an array of bioassays that can be used to evaluate the efficacy of intracellular delivery.
AB - Intracellular delivery of advanced therapeutics, including biologicals and supramolecular agents, is complex because of the natural biological barriers that have evolved to protect the cell. Efficient delivery of therapeutic nucleic acids, proteins, peptides and nanoparticles is crucial for clinical adoption of emerging technologies that can benefit disease treatment through gene and cell therapy. Nanoneedles are arrays of vertical high-aspect-ratio nanostructures that can precisely manipulate complex processes at the cell interface, enabling effective intracellular delivery. This emerging technology has already enabled the development of efficient and non-destructive routes for direct access to intracellular environments and delivery of cell-impermeant payloads. However, successful implementation of this technology requires knowledge of several scientific fields, making it complex to access and adopt by researchers who are not directly involved in developing nanoneedle platforms. This presents an obstacle to the widespread adoption of nanoneedle technologies for drug delivery. This tutorial aims to equip researchers with the knowledge required to develop a nanoinjection workflow. It discusses the selection of nanoneedle devices, approaches for cargo loading and strategies for interfacing to biological systems and summarises an array of bioassays that can be used to evaluate the efficacy of intracellular delivery.
UR - http://www.scopus.com/inward/record.url?scp=85113742320&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113742320&partnerID=8YFLogxK
U2 - 10.1038/s41596-021-00600-7
DO - 10.1038/s41596-021-00600-7
M3 - Review article
C2 - 34426708
AN - SCOPUS:85113742320
SN - 1754-2189
VL - 16
SP - 4539
EP - 4563
JO - Nature Protocols
JF - Nature Protocols
IS - 10
ER -